Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs aimed at growing the horizons of cytokine-based immunotherapy, especially for cancers where treatment method selections remain limited. Utilize the links below to learn extra about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline https://financefeeds.com/occ-appoints-j-p-morgans-michael-kurd-to-board-of-directors/